Clinical Trials List
Protocol Number107WHA0110215
Not yet recruiting
2018-08-01 - 2021-07-30
Others
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- 陳世彬 Division of Neurology
- 黃文盛 Division of Nuclear Medicine
- Hung-Yu Liu Division of Neurology
- YEN-FENG WANG Division of Neurology
- Shuu-Jiun Wang Division of Neurology
- 陳韋達 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40-60 participants
-
Global
40-60 participants
